The serotonin transporter is required for stress-evoked increases in adrenal catecholamine synthesis and angiotensin II AT2 receptor expression

被引:19
作者
Armando, I
Tjurmina, OA
Li, Q
Murphy, DL
Saavedra, JM
机构
[1] NIMH, Pharmacol Sect, NIH, Bethesda, MD 20892 USA
[2] NIMH, Clin Sci Lab, NIH, Bethesda, MD 20892 USA
关键词
tyrosine hydroxylase; angiotensins; angiotensin receptors; catecholamines; serotonin; serotonin transporter; adrenal medulla; stress; in situ hybridization;
D O I
10.1159/000073705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High numbers of serotonin transporter (SERT) binding sites and high serotonin (5-HT) content are expressed in the adrenal medulla of wild-type (SERT+/+) mice. Acute restraint stress increases adrenomedullary 5-HT, norepinephrine (NE) and epinephrine (E) release, adrenomedullary tyrosine hydroxylase (TH) mRNA, and angiotensin II AT(2) receptor expression. There are no alterations in adrenal catecholamine content during restraint. In litter-mate SERT-/- mice, which do not express SERT binding sites, the basal adrenomedullary 5-HT content is significantly reduced and does not increase after stress. The stress-induced increase in plasma E is higher in SERT-/- than in SERT+/+ animals. In SERT-/- mice, the stress-induced increase in expression of TH mRNA does not occur, and as a consequence, adrenal E content decreases, and adrenal E and NE content are lower than that of SERT+/+ mice during restraint. In addition, instead of increased expression, stress induces a profound decrease in the number of adrenomedullary AT2 receptors in SERT-/- mice. Our results indicate that SERT is necessary for the stress-induced increase in adrenomedullary catecholamine synthesis and AT2 receptor expression. These data further indicate a close relationship between the adrenomedullary 5-HT and angiotensin II systems, and an important role of adrenomedullary AT2 receptors in catecholamine synthesis and release during stress. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 43 条
[1]   Peripheral administration of an angiotensin II AT1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress [J].
Armando, I ;
Carranza, A ;
Nishimura, Y ;
Hoe, KL ;
Barontini, M ;
Terrón, JA ;
Falcón-Neri, A ;
Ito, T ;
Juorio, AV ;
Saavedra, JM .
ENDOCRINOLOGY, 2001, 142 (09) :3880-3889
[2]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[3]   Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice [J].
Bengel, D ;
Murphy, DL ;
Andrews, AM ;
Wichems, CH ;
Feltner, D ;
Heils, A ;
Mössner, R ;
Westphal, H ;
Lesch, KP .
MOLECULAR PHARMACOLOGY, 1998, 53 (04) :649-655
[4]   HIGH-AFFINITY BINDING OF [I-125] RTI-55 TO DOPAMINE AND SEROTONIN TRANSPORTERS IN RAT-BRAIN [J].
BOJA, JW ;
MITCHELL, WM ;
PATEL, A ;
KOPAJTIC, TA ;
CARROLL, FI ;
LEWIN, AH ;
ABRAHAM, P ;
KUHAR, MJ .
SYNAPSE, 1992, 12 (01) :27-36
[5]   Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters [J].
Chen, JJ ;
Li, ZS ;
Pan, H ;
Murphy, DL ;
Tamir, H ;
Koepsell, H ;
Gershon, MD .
JOURNAL OF NEUROSCIENCE, 2001, 21 (16) :6348-6361
[6]   Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells [J].
Contesse, V ;
Lefebvre, H ;
Lenglet, S ;
Kuhn, JM ;
Delarue, C ;
Vaudry, H .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 78 (12) :967-983
[7]   LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55 [J].
COULTER, CL ;
HAPPE, HK ;
BERGMAN, DA ;
MURRIN, LC .
BRAIN RESEARCH, 1995, 690 (02) :217-224
[8]   Immobilization stress-induced changes in brain acetylcholinesterase activity and cognitive function in mice [J].
Das, A ;
Kapoor, K ;
Sayeepriyadarshini, AT ;
Dikshit, M ;
Palit, G ;
Nath, C .
PHARMACOLOGICAL RESEARCH, 2000, 42 (03) :213-217
[9]   The AT2 receptor:: fact, fancy and fantasy [J].
de Gasparo, M ;
Siragy, HM .
REGULATORY PEPTIDES, 1999, 81 (1-3) :11-24
[10]  
Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877